At Science Progress, Scripps' Jeanne Loring explores the possibility that American researchers will soon be outsourcing their sequencing projects to China. China's sequencing capability is growing rapidly, she writes, pointing out that BGI has ordered 128 Illumina sequencers, bringing the total number of sequencers there to 157 — nearly double what the Broad Institute has. Instrument and reagent costs are only part of the price of sequencing, Loring says. "The Chinese will be able to achieve with DNA sequencing just what they attained in the manufacturing industry: the ability to do it cheaper and faster than anyone else," she says.